natur
outbreak
transmiss
gastroenter
tge
group
piglet
treat
oral
consecut
day
placebo
intern
unit
iu
natur
human
interferon
alpha
nhuifna
piglet
day
age
given
iu
nhuifna
significantli
greater
surviv
rate
placebotr
piglet
surviv
rate
greater
highest
level
nhuifncx
treatment
contrast
benefici
effect
nhuifncr
observ
piglet
farrow
diseas
outbreak
given
nhuifna
within
hour
birth
oral
nhuifna
therapi
modul
natur
cours
high
morbid
mortal
commonli
seen
tge
correspond
author
elsevi
scienc
bv
right
reserv
jm
cummin
et
al
veterinari
immunolog
andlmmunopatholog
transmiss
gastroenter
viru
tgev
coronaviru
caus
infecti
diseas
swine
result
diarrhea
dehydr
high
mortal
neonat
saif
bohl
sever
clinic
sign
invers
proport
age
anim
morbid
mortal
approach
piglet
less
day
age
dehydr
contribut
high
mortal
piglet
tge
aggrav
tgeassoci
agalactia
affect
sow
saif
bohl
virusspecif
gutassoci
secretori
iga
provid
direct
immunolog
protect
sprino
ristic
lactogen
iga
igg
provid
partial
protect
suckl
piglet
antibodi
level
high
infect
piglet
develop
less
sever
diseas
reduc
mortal
rate
saif
bohl
vaccin
neonat
piglet
induc
activ
immun
protect
develop
late
prevent
seriou
possibl
lethal
effect
tge
sprino
ristic
saif
bohl
ideal
approach
treatment
piglet
tge
epidem
might
provid
immedi
antivir
therapi
immun
respons
tge
viru
develop
although
human
interferon
alpha
huifnv
prepar
approv
use
man
defin
clinic
entiti
administ
parenter
pharmacolog
dose
million
iu
respons
therapi
often
disappoint
contrast
recent
data
demonstr
low
dose
ifna
administ
oral
caviti
benefici
treatment
varieti
diseas
sever
anim
speci
includ
swine
tompkin
cummin
cummin
hutcheson
cummin
hutcheson
hutchinson
et
al
lecc
et
al
object
studi
assess
efficaci
low
dose
oral
ifncv
therapi
piglet
natur
outbreak
tge
crude
natur
huifna
nhuifncu
induc
pool
human
leukocyt
sendai
viru
process
purifi
immunoaffin
chromatographi
acidif
gel
filtrat
chromatographi
interferon
scienc
inc
new
brunswick
nj
dilut
iu
per
ml
buffer
salin
solut
bss
dilut
assay
plaqu
reduct
determin
contain
iu
respect
preliminari
diagnosi
tge
made
attend
veterinarian
consult
one
author
bw
base
gener
field
criteria
tge
cross
bohl
infect
confirm
necropsi
histopatholog
examin
intestin
fluoresc
antibodi
test
tgev
antigen
frozen
tissu
pennsylvania
state
diagnost
laboratori
summerdal
pa
morin
et
al
jm
cummin
et
al
veterinari
immunolog
immunopatholog
piglet
studi
hybrid
stock
farrow
facil
natur
outbreak
tge
sow
suscept
tge
show
clinic
sign
test
presenc
viral
antigen
total
piglet
litter
age
newborn
day
treat
outbreak
piglet
treatment
respons
record
individu
litter
experiment
design
random
block
design
four
treatment
placebo
iu
nhuifna
per
piglet
per
day
experi
conduct
blind
treatment
identifi
four
color
code
red
blue
white
brown
litter
piglet
block
four
treatment
assign
within
four
litter
tgev
outbreak
progress
age
piglet
time
exposur
tge
vari
farrow
date
therefor
age
begin
treatment
group
follow
piglet
day
age
piglet
day
age
newborn
piglet
except
anim
die
piglet
treat
consecut
day
ml
final
volum
oral
regardless
clinic
condit
litter
least
four
piglet
prior
initi
treatment
includ
studi
data
analyz
analysi
dose
compar
placebo
within
age
group
p
valu
report
less
p
valu
consid
signific
treatment
group
respect
number
litter
piglet
surviv
rate
piglet
farrow
day
studi
period
list
tabl
greater
pc
surviv
rate
respect
piglet
given
placebo
surviv
data
analyz
age
treatment
tabl
piglet
litter
day
old
time
first
treatment
significantli
greater
surviv
rate
newborn
piglet
piglet
day
old
first
treat
probabl
expos
tgev
within
first
day
age
regardless
treatment
piglet
mean
surviv
rate
similarli
low
overal
surviv
rate
observ
newborn
piglet
litter
treatment
begun
day
farrow
piglet
like
expos
tgev
birth
mean
litter
size
three
age
group
day
day
newborn
respect
howev
piglet
die
treatment
began
mean
treat
litter
size
piglet
day
day
newborn
respect
surviv
piglet
within
day
age
group
favor
affect
treatment
piglet
day
old
nhuifna
increas
surviv
rate
placebo
iu
nhuifna
dosag
nhuifna
improv
surviv
rate
contrast
oral
nhuifna
treatment
newborn
piglet
significantli
improv
surviv
rate
compar
placebo
treatment
tge
devast
diseas
piglet
high
densiti
farrow
facil
prophylaxi
larg
limit
prevent
infect
exclus
tgevcontamin
materi
farrow
facil
altern
approach
prevent
vaccin
plan
natur
infect
pregnant
sow
case
specif
immunolog
protect
lethal
effect
tge
neonat
piglet
relat
level
tgevspecif
siga
concentr
gut
provid
passiv
matern
immun
colostrum
milk
saif
et
al
approach
success
pregnant
sow
immun
prior
farrow
suffici
lactogen
iga
avail
suckl
neonat
sow
vaccin
reduc
mortal
rate
morbid
within
herd
remain
high
unaccept
death
loss
rate
may
observ
tge
epidem
describ
studi
typic
diseas
highproduct
closedfarrow
facil
none
sow
vaccin
prior
outbreak
thu
pig
age
immunolog
naiv
suscept
tgev
although
exact
start
tge
outbreak
could
determin
epidem
well
establish
time
therapi
initi
surviv
data
collect
analyz
three
age
group
initi
nhuifna
therapi
benefici
effect
nhuifna
therapi
observ
day
old
piglet
three
dosag
nhuifna
effect
contrast
newborn
farrow
diseas
outbreak
treat
nhuifna
within
hour
birth
demonstr
signific
treatment
respons
variabl
effect
therapi
observ
studi
consist
modul
effect
mani
biolog
respons
modifi
includ
ifncu
factor
influenc
variabl
includ
dose
rout
ifna
therapi
relationship
age
time
exposur
infecti
agent
other
observ
ifna
therapi
infect
benefici
wherea
ifncw
therapi
prior
infect
contraind
oppenheim
et
al
similarli
high
dose
ifna
sometim
less
benefici
lower
dose
cummin
et
al
koech
et
al
young
et
al
thu
ifncv
therapi
tge
may
exhibit
dosedepend
effect
efficaci
may
also
vari
accord
age
time
exposur
tgev
effect
observ
field
trial
mechan
low
dose
oral
nhuifncv
provid
benefit
piglet
tge
outbreak
unknown
howev
porcin
blood
mononuclear
cell
known
secret
ifncw
induct
tgev
nowacki
et
al
ifn
product
gradual
increas
age
anim
benefici
effect
oral
nhuifna
therapi
observ
studi
may
relat
immun
respons
oral
ifn
therapi
studi
piglet
experiment
natur
rotaviru
infect
show
signific
weight
gain
benefit
reduct
enter
diseas
lecc
et
al
report
document
novel
therapi
tgev
infect
data
demonstr
oral
administ
nhuifna
provid
posit
surviv
benefit
day
old
tgevinfect
piglet
biolog
respons
modifi
magnitud
effect
vari
dose
use
age
anim
treat
stage
diseas
time
initi
therapi
although
mechan
determin
benefici
effect
describ
consist
data
obtain
speci
